Welcome to our dedicated page for Addus HomeCare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Addus HomeCare Corporation filings document a home care provider with personal care, hospice and home health operations. Form 8-K reports furnish quarterly and annual results of operations, Regulation FD disclosures and exhibit press releases, while amended 8-K filings provide acquisition-related financial statements and pro forma information for the completed purchase of Gentiva's personal care business by Addus HealthCare, a wholly owned subsidiary.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation votes and related governance disclosures. The filing record also includes capital-structure, material-event and shareholder-vote disclosures for the company's common stock.
Allison R. Dirk, Chairman and CEO of Addus HomeCare Corp. (ADUS), reported option exercise and stock sales on 08/20/2025. She exercised 25,000 employee stock options with a $19.71 exercise price, resulting in ownership of 25,000 shares from that exercise. On the same date she sold a total of 25,000 common shares in two blocks: 17,560 shares at a weighted average price of $114.71 and 7,440 shares at a weighted average price of $115.53. After these transactions her beneficial ownership is reported as 166,461 shares. The filing notes all options were fully vested and sale price ranges are provided in footnotes.
Form 4: Veronica Hill-Milbourne, a director of Addus HomeCare Corp. (ADUS), sold 1,571 shares of common stock on 08/19/2025 at a reported price of $114.93 per share, reducing her direct beneficial ownership to 5,067 shares. The filing was signed by an attorney-in-fact on 08/21/2025. This report discloses an insider sale and the remaining direct ownership stake held by the reporting person.
Addus HomeCare Corp. (ADUS) submitted a Form 144 disclosing a proposed sale of 25,000 common shares through Morgan Stanley Smith Barney LLC, scheduled for 08/20/2025. The filing shows the shares were acquired and paid for on 08/20/2025 via a stock option exercise with cash payment. The aggregate market value of the shares at filing is $2,873,862.50 and the company reports 18,407,239 shares outstanding. The filer reports no sales of the issuer’s securities in the past three months and includes the standard Rule 144 representation regarding possession of material nonpublic information.
Addus HomeCare Corp. (ADUS) filing a Form 144 notifies the proposed sale of 1,571 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $180,555.03 and an approximate sale date of 08/19/2025 on NASDAQ. The filer reports total outstanding shares of 18,407,239. The shares were acquired as restricted stock in three tranches: 1,013 on 06/12/2025, 104 on 06/16/2022, and 454 on 06/15/2021. The filing contains no reported sales in the past three months and includes the standard attestation about material nonpublic information.
Insider sales and a charitable gift reduced the reporting person’s stake in Addus HomeCare (ADUS). The reporting person sold a total of 9,000 shares in two blocks at weighted average prices around $114.18 and $115.49, reducing beneficial ownership from 50,505 shares to 42,505 shares and then to 41,605 shares after a subsequent gift. The filing also discloses a gift of 900 shares to a charitable organization, recorded with zero cash consideration. All transactions are reported as direct holdings.
Addus HomeCare Corp (ADUS) submitted a Form 144 notifying a proposed sale of 9,000 common shares to be executed through Morgan Stanley Smith Barney LLC on NASDAQ approximately 08/13/2025. The filing lists an aggregate market value of $1,038,105.90 and 18,407,239 shares outstanding, implying a per-share value near $115.35 and the sale representing about 0.05% of outstanding shares.
All 9,000 shares were issued as restricted stock across grants dated 03/01/2022, 02/23/2024, 02/24/2024 and 02/24/2025. The filing reports no securities sold in the past three months and includes the seller's certification that they are not aware of undisclosed material adverse information. The document provided does not identify the individual seller or include additional issuer contact details in the visible fields.
Addus HomeCare Corp. Schedule 13G reports that Capital Research Global Investors (CRGI) beneficially owns 1,102,298 shares of common stock, equal to 6.0% of the 18,399,139 shares reported outstanding. CRGI is described as a division of Capital Research and Management Company and related investment management entities and is deemed the beneficial owner through those entities. The filing states CRGI has sole voting power and sole dispositive power over all 1,102,298 shares and no shared powers. The filing certifies the securities are held in the ordinary course of business and not to influence control. SMALLCAP World Fund, Inc. is identified as an account referenced in the filing.
Wasatch Advisors LP reports beneficial ownership of 929,154 shares of Addus HomeCare common stock, representing 5.1% of the class. That level of ownership triggers Schedule 13G/A disclosure and identifies Wasatch as a material institutional holder of Addus HomeCare.
The filing states Wasatch has sole dispositive power over all 929,154 shares and sole voting power over 690,487 shares, with no shared voting or dispositive power. The document classifies Wasatch as an investment adviser organized in Delaware and includes a certification that the securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control of the issuer.
Esteban Lopez, a director of Addus HomeCare (ADUS), sold 522 shares of common stock on 08/08/2025 at $109 per share. After the sale he beneficially owns 4,016 shares held directly. The filing reports only this non-derivative sale, shows no derivative holdings, and does not disclose a 10b5-1 trading plan. The Form 4 was executed by an attorney-in-fact.
Addus HomeCare (ADUS) filed a Form 144 reporting a proposed resale of 522 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $56,898 and 18,407,239 shares outstanding. The filing lists an approximate sale date of 08/08/2025.
The securities were acquired as restricted stock from the issuer on 06/12/2025 with payment recorded the same day, and the filer reports "Nothing to Report" for sales in the past three months. This Form 144 is a notice of intended resale under Rule 144 and includes the seller's representation that they are not aware of any undisclosed material adverse information.